Metformin Teva (Metformin Hydrochloride)

Metformin Hydrochloride primarily inhibits mitochondrial complex I, which reduces gluconeogenesis in the liver. It also activates AMP‑activated protein kinase, enhancing peripheral insulin sensitivity and decreasing intestinal glucose absorption, resulting in lower circulating glucose levels.

The appropriate dose of Metformin Teva is determined by the prescribing healthcare professional based on individual patient factors such as renal function, glycemic targets, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformin may be used during pregnancy only if clearly needed and prescribed by a qualified clinician, as safety data are limited. It is excreted in breast milk, so a risk‑benefit assessment should be performed before breastfeeding while on metformin.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because of its efficacy, low risk of hypoglycemia and favorable impact on weight. Compared with sulfonylureas or insulin, metformin does not cause weight gain and has a well‑established safety profile when used appropriately.

Metformin Teva tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Metformin Teva is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically directed by a healthcare professional.

The most serious adverse effect is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Teva is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.